I work at the intersection of biology and technology—where the magic happens; where technologies that can change our lives, how we detect diseases and how we deliver healthcare are born. I combine both disciplines to understand which are the key signatures of biomolecules that are most relevant to their biological function and that could be used to improve disease diagnosis and/or treatment.
My journey to Australia, and the UQ, started in December 2012, when I was awarded a UQ-postdoctoral Fellowship and joined former Federation Fellow, Prof. Matt Trau's group at the Australian Institute for Bioengineering and Nanotechnology (AIBN). In this group, I lead a small group of researchers within Trau group to develop next-generation techniques for molecular and cellular biomarker discovery, detection and translation to clinical practice. This research has a particular emphasis on epigenetics applications—tools for detecting changes in the patterns and levels of tiny chemical groups, called methyl groups that are attached to our DNA and control which genes are turned on and off.
Prior to joining Trau Group at AIBN, I was a Postdoctoral Research Fellow at the Catalan Institute for Nanoscience and Nanotechnology (CIN2) in Barcelona, Spain, and Member of the Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) in Spain.
I have co-authored close to 50 publications including 3 book chapters, in high-ranking journals in their field, which you can check in my Google Scholar profile: https://scholar.google.es/citations?hl=es&user=zsQUmmIAAAAJ